Radiotherapy Delivery in Deep Inspiration for Pediatric Patients—Final Results of the Phase II Feasibility Study TEDDI

dc.contributor.authorØstergaard, Daniella Elisabet
dc.contributor.authorYoung Lundgaard, Anni
dc.contributor.authorRechner, Laura Ann
dc.contributor.authorDejanovic, Danijela
dc.contributor.authorKrogh Rose, Hanne
dc.contributor.authorHansen, Jolanta
dc.contributor.authorVaalavirta, Leila
dc.contributor.authorMokka, Miia
dc.contributor.authorAznar, Marianne
dc.contributor.authorWehner, Peder Skov
dc.contributor.authorHjalgrim, Lisa Lyngsie
dc.contributor.authorMaraldo, Maja Vestmø
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.converis.publication-id515628520
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/515628520
dc.date.accessioned2026-04-24T21:41:28Z
dc.description.abstract<h3>Introduction</h3><p>The TEDDI trial tested the feasibility and reproducibility of deep-inspiration breath-hold (DIBH) in pediatric patients referred for radiotherapy. This report presents final results, including patient-reported outcomes (PRO) and dosimetric comparison of DIBH and free-breathing (FB).</p><h3>Patients and Methods</h3><p>Pediatric patients able to perform three sequential breath-holds and potentially requiring thoracic or upper abdominal radiotherapy were recruited. DIBH training was during staging or planning computed tomography (CT) scanning, using external gating with an external marker and visual coaching. Each patient underwent planning CT in both DIBH and FB, generating two radiotherapy plans. DIBH was selected if it resulted in a lower overall dose to organs at risk. At two centers, patients evaluated their DIBH experience during training. Those treated in DIBH also completed three daily questions and extended questionnaires at the start, midpoint, and end of treatment, using yes/no and five-point Likert scales.</p><h3>Results</h3><p>Twenty-five patients (12 females/13 males, median age 15 years, range: 9–17 years) were enrolled across three centers. Eight received photon radiotherapy, five in DIBH. Of 13 eligible patients, 11 rated DIBH training, with 10 selecting “Really good” or “Good.” Patients treated in DIBH reported feeling safe and comfortable. Dosimetric analysis showed clear heart and lung dose reductions with DIBH. FB patients had similar doses across both plans.</p><h3>Conclusion</h3><p>The TEDDI trial demonstrated the feasibility and safety of DIBH in pediatric radiotherapy. High compliance with the procedure and favorable dosimetric outcomes support the use of DIBH to reduce long-term toxicity risks in this population.</p>
dc.identifier.eissn1545-5017
dc.identifier.jour-issn1545-5009
dc.identifier.urihttps://www.utupub.fi/handle/11111/59732
dc.identifier.urlhttps://doi.org/10.1002/1545-5017.70100
dc.identifier.urnURN:NBN:fi-fe2026042333390
dc.language.isoen
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.discipline3123 Gynaecology and paediatricsen_GB
dc.okm.discipline3123 Naisten- ja lastentauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherWiley
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.articlenumbere70100
dc.relation.doi10.1002/1545-5017.70100
dc.relation.ispartofjournalPediatric Blood and Cancer
dc.relation.issue4
dc.relation.volume73
dc.titleRadiotherapy Delivery in Deep Inspiration for Pediatric Patients—Final Results of the Phase II Feasibility Study TEDDI
dc.year.issued2026

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Pediatric Blood Cancer - 2026 - Østergaard - Radiotherapy Delivery in Deep Inspiration for Pediatric Patients Final.pdf
Size:
1.08 MB
Format:
Adobe Portable Document Format